Sanofi gets rated buy today ... I think could contribute to continued top-line performance is a diversified portfolio of ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Dupixent to Remain Sanofi's (SNY) Key Top-Line Driver The Zacks analyst expects Dupixent ... Decreased Demand Paper Related Products Hurts Xerox (XRX) Per the Zacks analyst, Xerox is grappling with ...

As head of HHS, Kennedy would lead a sprawling federal department that encompasses more than 100 programs supporting medicine ...

Saudi Arabia Pharmaceutical Drugs Market Projected To Witness Substantial Growth, 2024-2031: Pfizer Inc., Sanofi S. A. Saudi Arabia Pharmaceutical Drugs Market is estimated to be valued at US$ 12.60 ...

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including World <a target=_blank ...

The Nifty Pharma index closed 0.26 per cent at 21752.00. Benchmark NSE Nifty50 index ended down 26.35 points at 23532.7, ...

Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty ...

It sells products through independent distributors primarily in India.Sanofi India's products viz. Lantus Combiflam Amaryl and Allegra feature in the top 100 pharmaceutical brands in India. The ...

Vaccine makers hit hardest as Robert F. Kennedy Jr. appointment to Department of Health raises concerns for US drug market.

The revamp is the first major action by recently-appointed chief executive Olivier Brandicourt, who took the top job ... bundles Sanofi's generic medicines and older products still in patent ...

Critics believe Donald Trump's nominee to lead Health and Human Services poses a threat to the achievements of a ...